Stefanos Theoharis, Ph.D.
Dir. Corporate Development
TGF-β2 Inhibitor Trabedersen - A promising immunological therapeutic option in aggressive cancers
Antisense - innovative therapeutic approach to inhibit the synthesis of pathogenic proteins. Antisense Pharma is committed to research and development of innovative medicines; pursuing an immunotherapeutic strategy with a potentially long-lasting effect against malignant tumor diseases.